Brian Schulte

578 total citations
27 papers, 381 citations indexed

About

Brian Schulte is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Brian Schulte has authored 27 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Brian Schulte's work include Sarcoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (6 papers) and Vascular Tumors and Angiosarcomas (5 papers). Brian Schulte is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (6 papers) and Vascular Tumors and Angiosarcomas (5 papers). Brian Schulte collaborates with scholars based in United States, United Kingdom and Canada. Brian Schulte's co-authors include Ted Rosén, Dipica Haribhai, Youwen Zhou, Alexander C. Mackinnon, Calvin B. Williams, Xuesong Wu, Samuel Hwang, Jose A. Plaza, Wei Zhang and Enkhtsetseg Purev and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Brian Schulte

23 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Schulte United States 9 146 108 82 80 72 27 381
Massimiliano Di Marzo Italy 10 131 0.9× 59 0.5× 16 0.2× 65 0.8× 68 0.9× 30 370
Tayab Waseem United States 8 51 0.3× 258 2.4× 11 0.1× 44 0.6× 72 1.0× 12 408
Shaheer Khan United States 11 257 1.8× 135 1.3× 38 0.5× 70 0.9× 113 1.6× 28 430
Vasileia Damaskou Greece 10 106 0.7× 40 0.4× 45 0.5× 20 0.3× 59 0.8× 28 276
Katja Sockel Germany 12 77 0.5× 53 0.5× 14 0.2× 27 0.3× 87 1.2× 51 526
Neeraj Saini United States 13 233 1.6× 46 0.4× 35 0.4× 49 0.6× 88 1.2× 49 416
Toshiyuki Nakasone Japan 10 58 0.4× 23 0.2× 12 0.1× 47 0.6× 52 0.7× 45 244
Rony Weitzen Israel 11 186 1.3× 76 0.7× 31 0.4× 116 1.4× 103 1.4× 33 427
Akio Hirano Japan 12 124 0.8× 156 1.4× 32 0.4× 52 0.7× 45 0.6× 32 472
Alexander Thiem Germany 7 120 0.8× 67 0.6× 20 0.2× 37 0.5× 63 0.9× 31 271

Countries citing papers authored by Brian Schulte

Since Specialization
Citations

This map shows the geographic impact of Brian Schulte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Schulte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Schulte more than expected).

Fields of papers citing papers by Brian Schulte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Schulte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Schulte. The network helps show where Brian Schulte may publish in the future.

Co-authorship network of co-authors of Brian Schulte

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Schulte. A scholar is included among the top collaborators of Brian Schulte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Schulte. Brian Schulte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baik, Alan H., et al.. (2025). Statin Use in Patients With Cancer. JACC Advances. 4(11). 102259–102259.
2.
3.
Hwang, Caleb, Mark Agulnik, & Brian Schulte. (2024). Prices and Trends in FDA-Approved Medications for Sarcomas. Cancers. 16(8). 1545–1545. 1 indexed citations
4.
Schulte, Brian, Caleb Hwang, Andrew Horvai, & Timothée Olivier. (2024). When destiny doesn’t pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan. Cancer. 130(23). 4020–4024. 1 indexed citations
5.
Tap, William D., John A. Charlson, Lara E. Davis, et al.. (2024). 53O Results from a phase II part I trial of mecbotamab vedotin (BA3011), a CAB-AXL-ADC, in patients with advanced refractory sarcoma. ESMO Open. 9. 102443–102443. 5 indexed citations
6.
Schulte, Brian. (2023). Capacity of ChatGPT to Identify Guideline-Based Treatments for Advanced Solid Tumors. Cureus. 15(4). e37938–e37938. 40 indexed citations
7.
8.
Schulte, Brian, et al.. (2023). Targeted therapies for the treatment of soft tissue sarcoma. Frontiers in Oncology. 13. 1122508–1122508. 10 indexed citations
9.
Schulte, Brian, et al.. (2023). Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma. Frontiers in Oncology. 13. 1123464–1123464. 6 indexed citations
10.
11.
12.
Schroeder, Brett, Bonnie LaFleur, Rachel Gittelman, et al.. (2021). CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for ImmunoTherapy of Cancer. 9(8). e002812–e002812. 25 indexed citations
13.
Agulnik, Mark, Brian Schulte, Steven I. Robinson, et al.. (2021). An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. European Journal of Cancer. 154. 201–208. 17 indexed citations
14.
Schulte, Brian, Nisha Mohindra, Mohammed Milhem, et al.. (2021). Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. British Journal of Cancer. 125(4). 528–533. 15 indexed citations
15.
Principe, Daniel R., Brian Schulte, Suneel D. Kamath, & Hidayatullah G. Munshi. (2021). Glandular metastases from renal cell carcinoma show poor clinical responses to immune checkpoint inhibition but durable responses to angiogenesis inhibitors. BMJ Case Reports. 14(6). e243259–e243259. 1 indexed citations
16.
Schulte, Brian, et al.. (2021). Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report. The Oncologist. 26(7). 549–553. 8 indexed citations
17.
Wolcott, John, et al.. (2020). Development of Human-Out-of-the-Loop Participant Recruitment, Data Collection, Data Handling, and Participant Management System. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 64(1). 1770–1774. 1 indexed citations
18.
Zhang, Wei, Kimberly R. Jordan, Brian Schulte, & Enkhtsetseg Purev. (2018). Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS prodigy system. Drug Design Development and Therapy. Volume 12. 3343–3356. 35 indexed citations
19.
Wu, Xuesong, Brian Schulte, Youwen Zhou, et al.. (2014). Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo. Journal of Investigative Dermatology. 134(11). 2814–2822. 108 indexed citations
20.
Locasto, Michael E., Sergey Bratus, & Brian Schulte. (2009). Bickering In-Depth: Rethinking the Composition of Competing Security Systems. IEEE Security & Privacy. 7(6). 77–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimiliano Di Marzo Breakdown of academic impact, for papers by Tayab Waseem Breakdown of academic impact, for papers by Shaheer Khan Breakdown of academic impact, for papers by Vasileia Damaskou Breakdown of academic impact, for papers by Katja Sockel Breakdown of academic impact, for papers by Neeraj Saini Breakdown of academic impact, for papers by Toshiyuki Nakasone Breakdown of academic impact, for papers by Rony Weitzen Breakdown of academic impact, for papers by Akio Hirano Breakdown of academic impact, for papers by Alexander Thiem
Rankless by CCL
2026